Timothy Daley
Stock Analyst at Wells Fargo
(2.02)
# 3,092
Out of 5,044 analysts
58
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $47 | $47.95 | -2.65% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $8.13 | +146.00% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $96.45 | -1.50% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $38.72 | +85.95% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $145.85 | -0.58% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,404.58 | -7.45% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $345.95 | -17.62% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $216.90 | +13.88% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $187.93 | +46.33% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $259.69 | +3.97% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $6.16 | +354.55% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $25.78 | +35.76% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $557.63 | -6.75% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $1.34 | +571.64% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $151.57 | +22.06% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $74.01 | +14.85% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $218.13 | +0.86% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $177.73 | +23.78% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $15.08 | +85.68% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $178.28 | -21.47% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $63.94 | +40.76% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $47
Current: $47.95
Upside: -2.65%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $8.13
Upside: +146.00%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $96.45
Upside: -1.50%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $38.72
Upside: +85.95%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $145.85
Upside: -0.58%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,404.58
Upside: -7.45%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $345.95
Upside: -17.62%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $216.90
Upside: +13.88%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $187.93
Upside: +46.33%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $259.69
Upside: +3.97%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $6.16
Upside: +354.55%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $25.78
Upside: +35.76%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $557.63
Upside: -6.75%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $1.34
Upside: +571.64%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $151.57
Upside: +22.06%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $74.01
Upside: +14.85%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $218.13
Upside: +0.86%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $177.73
Upside: +23.78%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $15.08
Upside: +85.68%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $178.28
Upside: -21.47%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $63.94
Upside: +40.76%